Search results
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab...
FOX 23 News Albany· 6 days agoCPS<5. PRINCETON, N.J. and SUZHOU, China, May 23, 2024 /PRNewswire/ -- Transcenta Holding Limited...
Otsuka and Lundbeck report data from three PTSD treatment trials
Clinical Trials Arena via Yahoo Finance· 10 hours agoOtsuka Pharmaceutical Development & Commercialization and Lundbeck Pharmaceuticals have reported...
What's Going On With Biohaven Stock Wednesday? - Biohaven (NYSE:BHVN)
Benzinga· 2 hours agoThe Details: The company announced it dosed a patient with a new possible treatment for certain...
GeoVax to Present at BIO International Convention 2024
NewMediaWire via Yahoo Finance· 5 hours agoCompany to Provide Updates on Phase 2 Clinical Trials for COVID-19 Vaccine and...
Applied Research Center of Arkansas Joins hyperCORE International
Digital Journal· 11 hours agoHeadquartered in Little Rock, Applied Research Center of Arkansas (ARC) is a high quality, multi-specialty, research organization which has been serving Arkansas as a leading ...
RNA inhibitor is shown safe and effective in reducing a wide range of cholesterol and triglyceride...
Medical Xpress· 3 hours agoThe results were presented as a late-breaking clinical trial at the European Atherosclerosis Society...
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 23 hours agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
...Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including...
Digital Journal· 5 hours agoSHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines ...
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 1 day agoMerck & Co (MRK) announced on Tuesday that its phase 3 KEYNOTE-522 trial evaluating Keytuda...
HI-Bio reports findings from Phase II trial in kidney transplant recipients
Clinical Trials Arena via Yahoo Finance· 2 days agoHuman Immunology Biosciences (HI-Bio) has reported positive outcomes from the Phase II clinical ...